Cardiovascular Interactions of Halothane Anesthesia and Nifedipine in Patients Subjected to Elective Coronary Artery Bypass Surgery

Summary The effects of intravenous (iv) nifedipine (7.5 μg/kg over 10 min) on systemic hemodynamics and myocardial contractility were investigated under steady state conditions of halothane anesthesia (0.5 MAC) in 8 patients scheduled for elective coronary artery bypass surgery. All patients receive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Thoracic and cardiovascular surgeon 1983-10, Vol.31 (5), p.261-265
Hauptverfasser: Schulte-Sasse, U., Hess, W., Markschies-Hornung, A., Tarnow, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 265
container_issue 5
container_start_page 261
container_title The Thoracic and cardiovascular surgeon
container_volume 31
creator Schulte-Sasse, U.
Hess, W.
Markschies-Hornung, A.
Tarnow, J.
description Summary The effects of intravenous (iv) nifedipine (7.5 μg/kg over 10 min) on systemic hemodynamics and myocardial contractility were investigated under steady state conditions of halothane anesthesia (0.5 MAC) in 8 patients scheduled for elective coronary artery bypass surgery. All patients received long-term medication in the form of beta adrenergic receptor blockers and had a normal global left ventricular function at rest. Halothane produced a marked reduction in left ventricular contractility as documented by a considerable fall in LV max dP/dt. Nifedipine caused a small additional depression of LV max dP/dt without affecting LVEDP significantly. The slight myocardial depressant effect of nifedipine was counterbalanced by a concomitant reduction in left ventricular afterload due to a decrease in the systemic vascular resistance resulting in unchanged or even improved cardiac output. The results indicate that iv nifedipine in the doses used here is safe for patients with ischemic heart disease, even in the presence of already compromised myocardial contractility due to halothane anesthesia and chronic low-dose beta blocker therapy.
doi_str_mv 10.1055/s-2007-1021993
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1055_s_2007_1021993</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>6196857</sourcerecordid><originalsourceid>FETCH-LOGICAL-c328t-16b57249d94d63e703119d3e7d5c2c8a658a0b616d004f5bcc6cedfb5bbe7e3e3</originalsourceid><addsrcrecordid>eNp1UE1PAjEQbYwGEb16M-kfWGx3t93tEQkKCVET9bzptrNSsrSkLSSc_eOWQLx5mjd5H5l5CN1TMqaEsceQ5YRUGSU5FaK4QENaFiKjguSXaEhoRTNe5uwa3YSwJoSWdS0GaMCp4DWrhuhnKr02bi-D2vXS44WN4KWKxtmAXYfnsndxJS3giYUQVxCMxNJq_Go60GZrEmMsfpfRgI0Bf-zaNagIGkeHZ32CZg946ryz0h_wxKf4A346bGU4iv13Wm_RVSf7AHfnOUJfz7PP6Txbvr0sppNlpoq8jhnlLavyUmhRal5ARQpKhU5AM5WrWnJWS9JyyjUhZcdapbgC3bWsbaGCAooRGp9ylXcheOiarTebdFZDSXMsswnNsczmXGYyPJwM2127Af0nP7eX-OzEx5WBDTRrt_M2ffBf3i-OBYCb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cardiovascular Interactions of Halothane Anesthesia and Nifedipine in Patients Subjected to Elective Coronary Artery Bypass Surgery</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>Schulte-Sasse, U. ; Hess, W. ; Markschies-Hornung, A. ; Tarnow, J.</creator><creatorcontrib>Schulte-Sasse, U. ; Hess, W. ; Markschies-Hornung, A. ; Tarnow, J.</creatorcontrib><description>Summary The effects of intravenous (iv) nifedipine (7.5 μg/kg over 10 min) on systemic hemodynamics and myocardial contractility were investigated under steady state conditions of halothane anesthesia (0.5 MAC) in 8 patients scheduled for elective coronary artery bypass surgery. All patients received long-term medication in the form of beta adrenergic receptor blockers and had a normal global left ventricular function at rest. Halothane produced a marked reduction in left ventricular contractility as documented by a considerable fall in LV max dP/dt. Nifedipine caused a small additional depression of LV max dP/dt without affecting LVEDP significantly. The slight myocardial depressant effect of nifedipine was counterbalanced by a concomitant reduction in left ventricular afterload due to a decrease in the systemic vascular resistance resulting in unchanged or even improved cardiac output. The results indicate that iv nifedipine in the doses used here is safe for patients with ischemic heart disease, even in the presence of already compromised myocardial contractility due to halothane anesthesia and chronic low-dose beta blocker therapy.</description><identifier>ISSN: 0171-6425</identifier><identifier>EISSN: 1439-1902</identifier><identifier>DOI: 10.1055/s-2007-1021993</identifier><identifier>PMID: 6196857</identifier><language>eng</language><publisher>Germany</publisher><subject>Aged ; Anesthesia, Inhalation ; Coronary Artery Bypass ; Coronary Disease - drug therapy ; Coronary Disease - physiopathology ; Coronary Disease - surgery ; Dose-Response Relationship, Drug ; Drug Interactions ; Halothane - pharmacology ; Hemodynamics - drug effects ; Humans ; Infusions, Parenteral ; Intraoperative Period ; Male ; Middle Aged ; Myocardial Contraction - drug effects ; Nifedipine - pharmacology ; Nifedipine - therapeutic use</subject><ispartof>The Thoracic and cardiovascular surgeon, 1983-10, Vol.31 (5), p.261-265</ispartof><rights>Georg Thieme Verlag Stuttgart · New York</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c328t-16b57249d94d63e703119d3e7d5c2c8a658a0b616d004f5bcc6cedfb5bbe7e3e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-1021993.pdf$$EPDF$$P50$$Gthieme$$H</linktopdf><link.rule.ids>314,780,784,3016,3017,27923,27924,54558</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6196857$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schulte-Sasse, U.</creatorcontrib><creatorcontrib>Hess, W.</creatorcontrib><creatorcontrib>Markschies-Hornung, A.</creatorcontrib><creatorcontrib>Tarnow, J.</creatorcontrib><title>Cardiovascular Interactions of Halothane Anesthesia and Nifedipine in Patients Subjected to Elective Coronary Artery Bypass Surgery</title><title>The Thoracic and cardiovascular surgeon</title><addtitle>Thorac cardiovasc Surg</addtitle><description>Summary The effects of intravenous (iv) nifedipine (7.5 μg/kg over 10 min) on systemic hemodynamics and myocardial contractility were investigated under steady state conditions of halothane anesthesia (0.5 MAC) in 8 patients scheduled for elective coronary artery bypass surgery. All patients received long-term medication in the form of beta adrenergic receptor blockers and had a normal global left ventricular function at rest. Halothane produced a marked reduction in left ventricular contractility as documented by a considerable fall in LV max dP/dt. Nifedipine caused a small additional depression of LV max dP/dt without affecting LVEDP significantly. The slight myocardial depressant effect of nifedipine was counterbalanced by a concomitant reduction in left ventricular afterload due to a decrease in the systemic vascular resistance resulting in unchanged or even improved cardiac output. The results indicate that iv nifedipine in the doses used here is safe for patients with ischemic heart disease, even in the presence of already compromised myocardial contractility due to halothane anesthesia and chronic low-dose beta blocker therapy.</description><subject>Aged</subject><subject>Anesthesia, Inhalation</subject><subject>Coronary Artery Bypass</subject><subject>Coronary Disease - drug therapy</subject><subject>Coronary Disease - physiopathology</subject><subject>Coronary Disease - surgery</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Interactions</subject><subject>Halothane - pharmacology</subject><subject>Hemodynamics - drug effects</subject><subject>Humans</subject><subject>Infusions, Parenteral</subject><subject>Intraoperative Period</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial Contraction - drug effects</subject><subject>Nifedipine - pharmacology</subject><subject>Nifedipine - therapeutic use</subject><issn>0171-6425</issn><issn>1439-1902</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UE1PAjEQbYwGEb16M-kfWGx3t93tEQkKCVET9bzptrNSsrSkLSSc_eOWQLx5mjd5H5l5CN1TMqaEsceQ5YRUGSU5FaK4QENaFiKjguSXaEhoRTNe5uwa3YSwJoSWdS0GaMCp4DWrhuhnKr02bi-D2vXS44WN4KWKxtmAXYfnsndxJS3giYUQVxCMxNJq_Go60GZrEmMsfpfRgI0Bf-zaNagIGkeHZ32CZg946ryz0h_wxKf4A346bGU4iv13Wm_RVSf7AHfnOUJfz7PP6Txbvr0sppNlpoq8jhnlLavyUmhRal5ARQpKhU5AM5WrWnJWS9JyyjUhZcdapbgC3bWsbaGCAooRGp9ylXcheOiarTebdFZDSXMsswnNsczmXGYyPJwM2127Af0nP7eX-OzEx5WBDTRrt_M2ffBf3i-OBYCb</recordid><startdate>198310</startdate><enddate>198310</enddate><creator>Schulte-Sasse, U.</creator><creator>Hess, W.</creator><creator>Markschies-Hornung, A.</creator><creator>Tarnow, J.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>198310</creationdate><title>Cardiovascular Interactions of Halothane Anesthesia and Nifedipine in Patients Subjected to Elective Coronary Artery Bypass Surgery</title><author>Schulte-Sasse, U. ; Hess, W. ; Markschies-Hornung, A. ; Tarnow, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c328t-16b57249d94d63e703119d3e7d5c2c8a658a0b616d004f5bcc6cedfb5bbe7e3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Aged</topic><topic>Anesthesia, Inhalation</topic><topic>Coronary Artery Bypass</topic><topic>Coronary Disease - drug therapy</topic><topic>Coronary Disease - physiopathology</topic><topic>Coronary Disease - surgery</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Interactions</topic><topic>Halothane - pharmacology</topic><topic>Hemodynamics - drug effects</topic><topic>Humans</topic><topic>Infusions, Parenteral</topic><topic>Intraoperative Period</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial Contraction - drug effects</topic><topic>Nifedipine - pharmacology</topic><topic>Nifedipine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schulte-Sasse, U.</creatorcontrib><creatorcontrib>Hess, W.</creatorcontrib><creatorcontrib>Markschies-Hornung, A.</creatorcontrib><creatorcontrib>Tarnow, J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The Thoracic and cardiovascular surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schulte-Sasse, U.</au><au>Hess, W.</au><au>Markschies-Hornung, A.</au><au>Tarnow, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular Interactions of Halothane Anesthesia and Nifedipine in Patients Subjected to Elective Coronary Artery Bypass Surgery</atitle><jtitle>The Thoracic and cardiovascular surgeon</jtitle><addtitle>Thorac cardiovasc Surg</addtitle><date>1983-10</date><risdate>1983</risdate><volume>31</volume><issue>5</issue><spage>261</spage><epage>265</epage><pages>261-265</pages><issn>0171-6425</issn><eissn>1439-1902</eissn><abstract>Summary The effects of intravenous (iv) nifedipine (7.5 μg/kg over 10 min) on systemic hemodynamics and myocardial contractility were investigated under steady state conditions of halothane anesthesia (0.5 MAC) in 8 patients scheduled for elective coronary artery bypass surgery. All patients received long-term medication in the form of beta adrenergic receptor blockers and had a normal global left ventricular function at rest. Halothane produced a marked reduction in left ventricular contractility as documented by a considerable fall in LV max dP/dt. Nifedipine caused a small additional depression of LV max dP/dt without affecting LVEDP significantly. The slight myocardial depressant effect of nifedipine was counterbalanced by a concomitant reduction in left ventricular afterload due to a decrease in the systemic vascular resistance resulting in unchanged or even improved cardiac output. The results indicate that iv nifedipine in the doses used here is safe for patients with ischemic heart disease, even in the presence of already compromised myocardial contractility due to halothane anesthesia and chronic low-dose beta blocker therapy.</abstract><cop>Germany</cop><pmid>6196857</pmid><doi>10.1055/s-2007-1021993</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0171-6425
ispartof The Thoracic and cardiovascular surgeon, 1983-10, Vol.31 (5), p.261-265
issn 0171-6425
1439-1902
language eng
recordid cdi_crossref_primary_10_1055_s_2007_1021993
source MEDLINE; Thieme Connect Journals
subjects Aged
Anesthesia, Inhalation
Coronary Artery Bypass
Coronary Disease - drug therapy
Coronary Disease - physiopathology
Coronary Disease - surgery
Dose-Response Relationship, Drug
Drug Interactions
Halothane - pharmacology
Hemodynamics - drug effects
Humans
Infusions, Parenteral
Intraoperative Period
Male
Middle Aged
Myocardial Contraction - drug effects
Nifedipine - pharmacology
Nifedipine - therapeutic use
title Cardiovascular Interactions of Halothane Anesthesia and Nifedipine in Patients Subjected to Elective Coronary Artery Bypass Surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A21%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20Interactions%20of%20Halothane%20Anesthesia%20and%20Nifedipine%20in%20Patients%20Subjected%20to%20Elective%20Coronary%20Artery%20Bypass%20Surgery&rft.jtitle=The%20Thoracic%20and%20cardiovascular%20surgeon&rft.au=Schulte-Sasse,%20U.&rft.date=1983-10&rft.volume=31&rft.issue=5&rft.spage=261&rft.epage=265&rft.pages=261-265&rft.issn=0171-6425&rft.eissn=1439-1902&rft_id=info:doi/10.1055/s-2007-1021993&rft_dat=%3Cpubmed_cross%3E6196857%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/6196857&rfr_iscdi=true